Stansted, United Kingdom

Gary Thomas Borrett


Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Bishops Stortford, GB (1997)
  • Stansted, GB (1997 - 1999)

Company Filing History:


Years Active: 1997-1999

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Gary Thomas Borrett: Innovator in Pharmaceutical Chemistry

Introduction

Gary Thomas Borrett is a distinguished inventor based in Stansted, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work primarily focuses on the development of compounds that act as 5-HT1-like agonists, which have important implications in medical science.

Latest Patents

Among his latest patents, Borrett has developed enantiomers of carbazole derivatives that serve as 5-HT1-like agonists. These compounds are characterized by a specific formula, wherein R.sup.4 can be methyl or ethyl, along with their respective salts, solvates, or hydrates. The processes for preparing these compounds and the pharmaceutical compositions containing them are also detailed in his patents. The compounds of formula (+) are particularly noted for their agonistic properties.

Career Highlights

Borrett's career has been marked by his association with Smithkline Beecham Corporation, where he has contributed to various innovative projects. His expertise in pharmaceutical chemistry has enabled him to develop groundbreaking compounds that have the potential to enhance therapeutic options for patients.

Collaborations

Throughout his career, Borrett has collaborated with notable colleagues, including John Kitteringham and Roderick Alan Porter. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Gary Thomas Borrett is a prominent figure in the realm of pharmaceutical inventions, with a strong portfolio of patents that reflect his dedication to advancing medical science. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…